tiprankstipranks
Ocean Biomedical Faces Nasdaq Compliance Challenges
Company Announcements

Ocean Biomedical Faces Nasdaq Compliance Challenges

Don't Miss our Black Friday Offers:

Ocean Biomedical (OCEA) just unveiled an update.

Ocean Biomedical has been notified by Nasdaq of non-compliance due to its failure to file the mandatory Quarterly Report on time, linked to earlier delays in filing its annual report. While trading on Nasdaq remains unaffected for now, the company must submit a compliance plan by September 3, 2024, and file all overdue reports by October 14, 2024. Ocean Biomedical intends to resolve these filings promptly and has issued a press release regarding this notice.

Learn more about OCEA stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyOcean Biomedical receives noncompliance letter from Nasdaq
TheFlyOcean Biomedical, Molecure sign licensing agreement for YKL-40 inhibitors
TheFlyOcean Biomedical’s oncology platform included in new published study
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App